Robert B. Crain - May 5, 2021 Form 4 Insider Report for AGCO CORP /DE (AGCO)

Role
SVP, Gen. Mgr. North America
Signature
Lynnette D. Schoenfeld Attorney-in-Fact
Stock symbol
AGCO
Transactions as of
May 5, 2021
Transactions value $
-$3,503,937
Form type
4
Date filed
5/7/2021, 11:34 AM
Next filing
Jan 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGCO Common Stock Options Exercise $209K +3.3K +4.71% $63.47 73.3K May 5, 2021 Direct
transaction AGCO Common Stock Options Exercise $196K +2.68K +3.65% $73.14 76K May 5, 2021 Direct
transaction AGCO Common Stock Options Exercise $229K +3.65K +4.8% $62.85 79.7K May 5, 2021 Direct
transaction AGCO Common Stock Options Exercise $185K +2.55K +3.2% $72.74 82.2K May 5, 2021 Direct
transaction AGCO Common Stock Tax liability -$1.29M -8.46K -10.28% $152.12 73.8K May 5, 2021 Direct
transaction AGCO Common Stock Sale -$3.04M -20K -27.11% $151.88 53.8K May 5, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGCO Stock Appreciation Right Options Exercise $0 -3.3K -100% $0.00* 0 May 5, 2021 Common Stock 3.3K $63.47 Direct F2
transaction AGCO Stock Appreciation Right Options Exercise $0 -2.68K -50% $0.00 2.68K May 5, 2021 Common Stock 2.68K $73.14 Direct F3
transaction AGCO Stock Appreciation Right Options Exercise $0 -3.65K -33.33% $0.00 7.3K May 5, 2021 Common Stock 3.65K $62.85 Direct F4
transaction AGCO Stock Appreciation Right Options Exercise $0 -2.55K -25% $0.00 7.65K May 5, 2021 Common Stock 2.55K $72.74 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $ 151.75 to $ 152.185, inclusive. The reporting person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
F2 Exercisable in four equal annual installments beginning January 24, 2018.
F3 Exercisable in four equal annual installments beginning January 23, 2019.
F4 Exercisable in four equal annual installments beginning January 22, 2020.
F5 Exercisable in four equal annual installments beginning January 22, 2021.